These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 21266668

  • 1. Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats.
    Koeners MP, Wesseling S, Ulu A, Sepúlveda RL, Morisseau C, Braam B, Hammock BD, Joles JA.
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E691-8. PubMed ID: 21266668
    [Abstract] [Full Text] [Related]

  • 2. Targeting arachidonic acid pathway to prevent programmed hypertension in maternal fructose-fed male adult rat offspring.
    Tain YL, Lee WC, Wu KLH, Leu S, Chan JYH.
    J Nutr Biochem; 2016 Dec; 38():86-92. PubMed ID: 27732913
    [Abstract] [Full Text] [Related]

  • 3. An epoxide hydrolase inhibitor, 12-(3-adamantan-1-yl-ureido)dodecanoic acid (AUDA), reduces ischemic cerebral infarct size in stroke-prone spontaneously hypertensive rats.
    Dorrance AM, Rupp N, Pollock DM, Newman JW, Hammock BD, Imig JD.
    J Cardiovasc Pharmacol; 2005 Dec; 46(6):842-8. PubMed ID: 16306811
    [Abstract] [Full Text] [Related]

  • 4. Novel mechanism of brain soluble epoxide hydrolase-mediated blood pressure regulation in the spontaneously hypertensive rat.
    Sellers KW, Sun C, Diez-Freire C, Waki H, Morisseau C, Falck JR, Hammock BD, Paton JF, Raizada MK.
    FASEB J; 2005 Apr; 19(6):626-8. PubMed ID: 15659536
    [Abstract] [Full Text] [Related]

  • 5. Early postnatal treatment with soluble epoxide hydrolase inhibitor or 15-deoxy-Δ(12,14)-prostagandin J2 prevents prenatal dexamethasone and postnatal high saturated fat diet induced programmed hypertension in adult rat offspring.
    Lu PC, Sheen JM, Yu HR, Lin YJ, Chen CC, Tiao MM, Tsai CC, Huang LT, Tain YL.
    Prostaglandins Other Lipid Mediat; 2016 Jul; 124():1-8. PubMed ID: 27210044
    [Abstract] [Full Text] [Related]

  • 6. Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension.
    Jung O, Brandes RP, Kim IH, Schweda F, Schmidt R, Hammock BD, Busse R, Fleming I.
    Hypertension; 2005 Apr; 45(4):759-65. PubMed ID: 15699457
    [Abstract] [Full Text] [Related]

  • 7. Soluble epoxide inhibition is protective against cerebral ischemia via vascular and neural protection.
    Simpkins AN, Rudic RD, Schreihofer DA, Roy S, Manhiani M, Tsai HJ, Hammock BD, Imig JD.
    Am J Pathol; 2009 Jun; 174(6):2086-95. PubMed ID: 19435785
    [Abstract] [Full Text] [Related]

  • 8. Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.
    Olearczyk JJ, Quigley JE, Mitchell BC, Yamamoto T, Kim IH, Newman JW, Luria A, Hammock BD, Imig JD.
    Clin Sci (Lond); 2009 Jan; 116(1):61-70. PubMed ID: 18459944
    [Abstract] [Full Text] [Related]

  • 9. An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension.
    Imig JD, Zhao X, Zaharis CZ, Olearczyk JJ, Pollock DM, Newman JW, Kim IH, Watanabe T, Hammock BD.
    Hypertension; 2005 Oct; 46(4):975-81. PubMed ID: 16157792
    [Abstract] [Full Text] [Related]

  • 10. Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats.
    Elmarakby AA, Faulkner J, Pye C, Rouch K, Alhashim A, Maddipati KR, Baban B.
    Clin Sci (Lond); 2013 Oct; 125(7):349-59. PubMed ID: 23611540
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Soluble epoxide hydrolase inhibition ameliorates proteinuria-induced epithelial-mesenchymal transition by regulating the PI3K-Akt-GSK-3β signaling pathway.
    Liang Y, Jing Z, Deng H, Li Z, Zhuang Z, Wang S, Wang Y.
    Biochem Biophys Res Commun; 2013 Oct; 463(1-2):70-5. PubMed ID: 25986738
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Differential cardiotoxicity in response to chronic doxorubicin treatment in male spontaneous hypertension-heart failure (SHHF), spontaneously hypertensive (SHR), and Wistar Kyoto (WKY) rats.
    Sharkey LC, Radin MJ, Heller L, Rogers LK, Tobias A, Matise I, Wang Q, Apple FS, McCune SA.
    Toxicol Appl Pharmacol; 2013 Nov 15; 273(1):47-57. PubMed ID: 23993975
    [Abstract] [Full Text] [Related]

  • 17. Soluble Epoxide Hydrolase Inhibition Attenuates Excitotoxicity Involving 14,15-Epoxyeicosatrienoic Acid-Mediated Astrocytic Survival and Plasticity to Preserve Glutamate Homeostasis.
    Kuo YM, Hsu PC, Hung CC, Hu YY, Huang YJ, Gan YL, Lin CH, Shie FS, Chang WK, Kao LS, Tsou MY, Lee YH.
    Mol Neurobiol; 2019 Dec 15; 56(12):8451-8474. PubMed ID: 31257558
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of soluble epoxide hydrolase does not protect against endotoxin-mediated hepatic inflammation.
    Fife KL, Liu Y, Schmelzer KR, Tsai HJ, Kim IH, Morisseau C, Hammock BD, Kroetz DL.
    J Pharmacol Exp Ther; 2008 Dec 15; 327(3):707-15. PubMed ID: 18815352
    [Abstract] [Full Text] [Related]

  • 19. Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.
    Jiang H, Quilley J, Doumad AB, Zhu AG, Falck JR, Hammock BD, Stier CT, Carroll MA.
    Am J Physiol Heart Circ Physiol; 2011 Jun 15; 300(6):H1990-6. PubMed ID: 21398593
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.